Colorectal Adenoma Canceration in FAP

Familial Adenomatous Polyposis Clinical Trial

Official title:

Cohort Study on Colorectal Adenoma Canceration in Familial Adenomatous Polyposis

Clinical Trial Details — Status: Not yet recruiting

Administrative data

• NCT number: NCT04531930
• Other study ID #: SINOFAP2020A
• Status: Not yet recruiting
• Start date: October 1, 2020
• Est. completion date: September 30, 2030

Study information

• Verified date: August 2020
• Source: Changhai Hospital
• Contact: En-Da YU, MBBS
• Phone: 8613901688626
• Email: endayu[@]yeah.net
• Is FDA regulated: No
• Study type: Observational [Patient Registry]

Clinical Trial Summary

The current internationally accepted treatment method for familial adenomatous polyposis is prophylactic total colorectal resection combined with endoscopic follow-up. However, total colorectal resection will bring a sharp decline in the quality of life of patients. Therefore, how to improve treatment methods and improve the quality of life for such patients under the premise of medical quality is the current medical focus. This study intends to establish three parallel observation cohorts, namely the surgical treatment group, the intensive colonoscopy treatment group, and the autonomous monitoring group. During the three-year study period, the investigators observed changes in the number of adenomas, carcinogenesis, and medical expenses in each group during the 3-year study period, and compared the groups to determine whether the intensive colonoscopy therapy has the possibility of delaying or replacing preventive surgery.

Description:

Familial adenomatous polyposis is a kind of colorectal cancer syndrome, which belongs to rare diseases. It is estimated that the number of patients in China is about 100,000, accounting for about 1% of all colorectal cancer patients. This type of patients onset between the ages of ten and thirty years old. The typical manifestation is the growth of tens to thousands of colorectal adenomas, and the lifetime risk of colorectal cancer is close to 100%, accompanied by multiple extraintestinal manifestations . Without treatment, the average life span is 40-50 years. The current internationally accepted treatment method is prophylactic total colorectal resection combined with endoscopic follow-up. This program has a significant effect and can extend life expectancy by 10-20 years. However, total colorectal resection will bring a sharp decline in the quality of life of patients. The patients will lose many abilities (working ability, social ability, fertility, etc.) from the age of 20, and the prolonged survival period also brings more misery. This, in turn, also reduces the compliance of treatment. Many patients refuse to accept surgery and turn to endoscopic treatment or even give up treatment. However, there is currently no evidence that methods other than prophylactic surgery can effectively control the risk of colorectal cancer in such patients. Therefore, how to improve treatment methods and improve the quality of life for such patients under the premise of medical quality is the current medical focus. This study intends to establish three parallel observation cohorts, namely the surgical treatment group, the intensive colonoscopy treatment group, and the autonomous monitoring group. Among them, the intensive colonoscopy treatment group will be treated with colonoscopy intensive treatment (that is, colonoscopy treatment is performed every 3 months, Carry out colorectal tumor reduction in segments, and continue to control the growth of adenomas several times) for patients who refuse surgery. During the three-year study period, the investigators observed changes in the number of adenomas, carcinogenesis, and medical expenses in each group during the 3-year study period, and compared the groups to determine whether the intensive colonoscopy therapy has the possibility of delaying or replacing preventive surgery, so as to explore ways to improve the quality of life of such patients.

Recruitment information / eligibility

• Status: Not yet recruiting
• Enrollment: 124
• Est. completion date: September 30, 2030
• Est. primary completion date: September 30, 2023
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years to 40 Years

Eligibility

Inclusion Criteria:

• The initial number of polyps is between 100-1000 visually;

• Pathological diagnosis of multiple lesions confirmed colorectal adenoma;

• Germline mutation detection is clearly a point mutation or large deletion of APC gene;

• No cancer or distant metastasis.

Exclusion Criteria:

• Age <18, or >40 years old;

• The initial number of polyps is <100, or >1000;

• The polyp has become cancerous or has suspected distant metastasis;

• Patients with intestinal obstruction, intestinal perforation, intestinal bleeding and other patients who need emergency surgical resection;

• Past history of colorectal surgery;

• Suffering from malignant tumors in other parts and requiring treatment or using chemotherapy drugs or NSAIDs;

• The patient has contraindications to colonoscopy;

• Patients or family members cannot understand the conditions and goals of this study;

• The patient plans to receive surgical treatment of preventive colorectal resection;

• Other reasons considered by the study doctor to be inappropriate for inclusion in the study.

Related Conditions & MeSH terms

• Adenoma
• Adenomatous Polyposis Coli
• Familial Adenomatous Polyposis

Intervention

Procedure:
• surgery
Colorectal surgery, mainly total proctocolectomy.
• enhanced colonoscopy
Colonoscopic treatment and surveillance in every 3 months.

Other:
• self choosed methods
A patient chooses a method for himself other than surgery.

Locations

Country	Name	City	State
China	Changhai Hospital	Shanghai	Shanghai

Sponsors (1)

Lead Sponsor	Collaborator
Changhai Hospital

Country where clinical trial is conducted

China, 

References & Publications (2)

Bülow S. Results of national registration of familial adenomatous polyposis. Gut. 2003 May;52(5):742-6. — View Citation

Karstensen JG, Burisch J, Pommergaard HC, Aalling L, Højen H, Jespersen N, Schmidt PN, Bülow S. Colorectal Cancer in Individuals With Familial Adenomatous Polyposis, Based on Analysis of the Danish Polyposis Registry. Clin Gastroenterol Hepatol. 2019 Oct;17(11):2294-2300.e1. doi: 10.1016/j.cgh.2019.02.008. Epub 2019 Feb 8. — View Citation

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	3yCR	3 year Cancerous rate	3 years
Secondary	Adenoma number Change	Change of adenoma number by 3 years	3 years
Secondary	3yOSR	3 year overall survival rate	3 years